{"transactions":[{"id":4188895,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T17:56:56.000Z","date":"2017-10-10","kind":"grant","acquired":true,"shares":20997,"price":0.38,"value":7978.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":56950,"source":{"system":"sec-edgar","filing":"0001394548-17-000031","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297696/000139454817000031/primary_doc.xml","form_type":"4"}},{"id":4261656,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-06T17:36:22.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's 2016 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option will vest and become exercisable in equal quarterly installments over one year beginning three months from June 8, 2017, such that the option will be fully exercisable as of June 8, 2018."}],"balance_after":5000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001394548-17-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1297696/000139454817000023/primary_doc.xml","form_type":"4"}},{"id":4261655,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T17:36:22.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":13390,"price":0.59,"value":7900.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be pain in unrestricted shares of the Company's common stock delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":35953,"source":{"system":"sec-edgar","filing":"0001394548-17-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297696/000139454817000023/primary_doc.xml","form_type":"4"}},{"id":4292803,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-05T21:31:23.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated."}],"balance_after":35000,"derivative":{"exercise_price":5.45,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001250853-17-000050","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085317000050/primary_doc.xml","form_type":"4"}},{"id":4353383,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-12T17:06:18.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":13394,"price":0.59,"value":7902.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payment to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":22563,"source":{"system":"sec-edgar","filing":"0001394548-17-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297696/000139454817000016/primary_doc.xml","form_type":"4"}},{"id":4482889,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":172590,"kind":"person","name":"Hillsberg Sanford","position":1,"cik":"0001297696","reported_name":"Hillsberg Sanford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-24T18:05:20.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":3998,"price":1.98,"value":7916.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":9169,"source":{"system":"sec-edgar","filing":"0001394548-17-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297696/000139454817000007/primary_doc.xml","form_type":"4"}}]}